Rick Doblin has been one of the few medical doctors in the United States, or actually make that more or less anywhere in the developed world, willing to stick his neck out and conduct clinical trials of psychedelic drugs.
His work has been variously profiled by the alternative press (including, of course, Under The Influence: The Disinformation Guide to Drugs), but it seems that his time may finally have come for some mainstream acceptance. Benedict Carey profiles the work of Doblin’s Multidisciplinary Association for Psychedelic Studies (MAPS) organization for the New York Times:
Hundreds of Iraq and Afghanistan veterans with post-traumatic stress have recently contacted a husband-and-wife team who work in suburban South Carolina to seek help. Many are desperate, pleading for treatment and willing to travel to get it.
The soldiers have no interest in traditional talking cures or prescription drugs that have given them little relief. They are lining up to try an alternative: MDMA, better known as Ecstasy, a party drug that surfaced in the 1980s and ’90s that can induce pulses of euphoria and a radiating affection. Government regulators criminalized the drug in 1985, placing it on a list of prohibited substances that includes heroin and LSD. But in recent years, regulators have licensed a small number of labs to produce MDMA for research purposes.
“I feel survivor’s guilt, both for coming back from Iraq alive and now for having had a chance to do this therapy,” said Anthony, a 25-year-old living near Charleston, S.C., who asked that his last name not be used because of the stigma of taking the drug. “I’m a different person because of it.”
In a paper posted online Tuesday by the Journal of Psychopharmacology, Michael and Ann Mithoefer, the husband-and-wife team offering the treatment — which combines psychotherapy with a dose of MDMA — write that they found 15 of 21 people who recovered from severe post-traumatic stress in the therapy in the early 2000s reported minor to virtually no symptoms today. Many said they have received other kinds of therapy since then, but not with MDMA.
The Mithoefers — he is a psychiatrist and she is a nurse — collaborated on the study with researchers at the Medical University of South Carolina and the nonprofit Multidisciplinary Association for Psychedelic Studies…
[continues in the New York Times]
Latest posts by majestic (see all)
- Creatives, designers and drugs: what are they on, and why? - May 16, 2016
- Why We Keep Dreaming of Little Green Men - May 15, 2016
- What Is The Value Of Conspiracy? - May 13, 2016